Market Brief: Global Orthobiologics Market Will Reach $2.3Bn By 2023 With Highest Growth In Cartilage Replacement
Executive Summary
The global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration is expected to reach $2.3bn by 2023, according to a new report by Informa's Meddevicetracker. This highly competitive market, which is led by Arthrex and other large and smaller players, continues to grow amid the rising prevalence of musculoskeletal soft tissue injuries and osteoarthritis. High prices of implants, the limited availability of donated tissue and limited reimbursement for synthetic scaffolds are limiting growth in this market.
You may also be interested in...
Exec Chat: Omron’s Hypertension Solutions Gain Traction With Shift To At-Home Patient Care
Omron is implementing its new VitalSight platform to physicians, hospitals for remote monitoring of high-risk hypertension patients at 50 US institutions and internationally.
Device Week, 28 April 2021 – Innovative Technologies In Diabetes; Future Of Surgery
In this week’s podcast, Medtech Insight's Barnaby Pickering features Finnish start-up GlucoModicum, which created a way to measure blood glucose levels without using needles. Managing editor Marion Webb discusses her latest Market Intel, which highlights three companies that developed technologies to help surgeons collaborate with remote surgical experts, including medical device specialists.
Medtronic Taps AR Technology Used By Fighter Pilots To Enhance Brain Surgery
Medtronic teamed up with Surgical Theater to integrate its SyncAR technology with its StealthStation S8 surgical navigation platform to help neurosurgeons navigate complex brain surgeries.